Murakami Soichiro, Samejima Ryuichiro, Sumi Kenji, Hidaka Katsuhiko
Dept. of Surgery, Takeo City Hospital.
Gan To Kagaku Ryoho. 2007 Jun;34(6):915-8.
The patient was a 42-year-old female diagnosed with unresectable highly advanced gastric cancer complicated by peritoneal dissemination. We performed systemic chemotherapy with MTX+5-FU as the first-line treatment, which stabilized the disease. Since the patient initially wished a radical resection, we tried chemotherapy with weekly PTX as a second-line treatment. Her therapeutic response remained between a partial response and a stable disease for about five months, followed, however, by progressive disease. The result of the third-line treatment with CPT-11+CDDP was again a progressive disease, so we switched her regimen to single-agent S-1 as a fourth-line treatment. The ascites disappeared three months after the change in regimen. As of March 2006, the patient had survived for 17 months since diagnosis (8 months since the ongoing S-1 therapy started) and the disease is currently stabilized, and preserving a favorable performance status. However, in June 2006, the patient died of pneumonia 20 months after the diagnosis.
该患者为一名42岁女性,被诊断为无法切除的高度进展期胃癌并伴有腹膜播散。我们采用MTX + 5 - FU进行全身化疗作为一线治疗,病情得以稳定。由于患者最初希望进行根治性切除,我们尝试使用每周一次的紫杉醇(PTX)进行化疗作为二线治疗。她的治疗反应在部分缓解和病情稳定之间维持了约五个月,但随后病情进展。使用伊立替康(CPT - 11)+顺铂(CDDP)进行三线治疗的结果仍是病情进展,因此我们将她的治疗方案改为单药S - 1作为四线治疗。方案改变三个月后腹水消失。截至2006年3月,患者自确诊以来已存活17个月(自开始进行当前的S - 1治疗起8个月),目前病情稳定,身体状况良好。然而,2006年6月,该患者在确诊20个月后死于肺炎。